Specialized Ophthalmology in Seoul · Dedicated International Patient Concierge
MOHW Registered · Foreign Patient Care
en-US
Medical Guide
Is LASIK Safe in Korea? Certification and Real Risks
Is LASIK safe in Korea? What ministry registration, specialty certification and device approval each prove — and the risks that none of the three remove.
Schedule a ConsultationIs LASIK Safe in Korea? Three Layers of Regulation, and Their Limits
Medically reviewed by Dr. Kim Byoung Jin, Board-certified ophthalmologist (Korean Ophthalmological Society)
Asking whether LASIK is safe in Korea usually produces the wrong kind of answer. Search and you get certificates: a ministry registration, a society membership, a laser with a regulator's approval attached. Each is real. None answers the question you asked.
The confusion is structural. Three separate regulatory systems sit behind an eye clinic that treats international patients. They are governed by different bodies, granted on different evidence, and answer different questions — yet patients read them as one stack of proof. This article takes them apart, says what each certifies, and then says plainly what remains uncertified after all three are in place.
Three questions hiding inside one word
"Safe" is doing too much work. Break it and three distinct questions fall out.
The first is institutional: is this a real, permitted, legally accountable place, or something that exists mainly as a website? The second is professional: has the person holding the instruments completed recognized training in this specialty? The third is clinical: what can go wrong with this operation, in competent hands, in a well-run facility, on a properly maintained machine?
Korea's regulatory architecture addresses the first directly, the second at the level of a specialty rather than a procedure, and the third hardly at all. Knowing which layer answers which is the difference between due diligence and reassurance-shopping.
Layer one: the institution and the health ministry's register
Korea operates a national registration scheme for medical institutions that set out to treat patients arriving from other countries. The Ministry of Health and Welfare administers the framework, and the enabling statute is the Medical Overseas Expansion and Foreign Patients Attraction Act. Medical Korea, the government-side portal for foreign patients, publishes the system's description in English.
Registration is a threshold. An institution that wants to receive inbound international patients enters the ministry's system for that purpose and appears in its records. That establishes that a specific, identified legal entity has stepped into a supervised category and accepted its conditions. It establishes no judgment about how the entity performs once inside.
A registration scheme creates a list of who may act, and a mechanism for removing them from it. It is a gatekeeping instrument, not a report card, and nobody visited an operating room to grant it.
The insurance condition, and why it is the substantive part
Inside the registration scheme sits the condition that carries the most real-world weight for a patient traveling from the United States. Medical Korea describes a requirement, in force since 2016, that registered institutions carry medical malpractice liability insurance — a ministry condition introduced to protect patients arriving from abroad.
Read it as what it is: a financial-responsibility rule. It does not make an operation go better. It means that if something goes wrong and liability is established, coverage is meant to stand behind the institution rather than only the institution's own resources. For a patient whose home legal system does not follow them overseas, that is not trivial.
It also has a shape worth recognizing. Insurance is a remedy that operates after harm, through a claims process, in a foreign jurisdiction, in a language you probably do not read. The Centers for Disease Control and Prevention, in its Yellow Book guidance on medical travel, notes that legal recourse for care received abroad can be limited. A coverage requirement narrows that gap without closing it, and treating it as a safety guarantee inverts what it is for.
The public directory, and what a register entry actually contains
You do not have to accept a clinic's word that it is registered. Medical Korea maintains a public directory of registered institutions, searchable and filterable by facility type and by region, and it encourages patients to confirm a clinic's registration certificate directly.
Look at the fields a directory record carries: a registration identifier, a location, and contact details for the institution's international healthcare desk. That is the whole evidentiary payload. An identifier makes the entry specific rather than a category, a location ties the entity to a physical address, and a contact route shows there is a designated point of entry for foreign patients.
Notice what no field contains. There is no outcome column, no complication rate, no volume figure, no rating. A register lists who is in the system, and the honest way to use it is as a filter that removes the unregistered rather than a ranking of the registered.
Jamsil Samsung Eye Clinic documents this status for itself. The designation reads "Registered Medical Institution for Attracting Foreign Patients," and the Ministry confers it under the Act named above. Its website sets out how it presents itself; the register is where you test that presentation against a government record.
Registration and accreditation are two different programs
This is the error that costs readers the most, and it is easy to make because the words feel interchangeable in English.
Medical Korea describes two things: a registration system for institutions treating foreign patients, and a separate accreditation program. They are not the same instrument, and one is not a stronger version of the other. Registration is entry into a supervised category subject to stated conditions. Accreditation is an additional evaluation, and being registered does not mean an institution has been through it.
So when a clinic page says "certified by the Ministry of Health and Welfare," the accurate reading is that it holds the registration. Whether it also holds accreditation is a second, separate question needing a second, separate answer in writing. Assuming the first implies the second is how a gatekeeping record gets silently upgraded into a quality award.
Layer two: the physician and the national specialty society
The second layer sits on a person rather than a building, and a professional body grants it rather than a government department.
Ophthalmology's national specialty society in Korea is the Korean Ophthalmological Society. It is the field's professional home: it publishes peer-reviewed journals, hosts subspecialty societies covering cornea, refractive and cataract surgery, retina, glaucoma and contact lenses, and maintains a directory of its members.
What a national specialty society certifies is training. Certification means a physician completed a recognized residency in that specialty and satisfied the society's examination and standards — a statement about a completed program of education, made by the professional community that defines what that education contains.
Certification is specialty-level, not procedure-level
Here is where a US reader's instinct misfires. Board certification is close to universal among practicing ophthalmologists, in Korea as in the United States. Confirming it eliminates the person who never trained in the specialty. It does not distinguish among the many who did.
Certification covers the specialty as a whole — the eye, its diseases, its surgery. It is not a certificate in refractive surgery. No specialty society publishes per-surgeon outcome data, ranks its members, or attaches a volume figure to a certificate. The subspecialty structure is where refractive expertise is organized, and membership in a subspecialty group signals engagement with that area rather than measured competence in it.
That reframes the useful question. "Is the surgeon board-certified?" has a predictable answer and low information value. The Food and Drug Administration's LASIK material points at a sharper one: ask how much experience the surgeon has with the specific laser platform your procedure would use. Only the clinic can answer that.
Jamsil Samsung Eye Clinic documents four ophthalmologist directors and an arrangement in which the operating surgeon personally handles pre-operative and post-operative care, one doctor following a patient from consultation through aftercare. Confirm in writing that this applies to your case, because it determines whose experience is the relevant experience.
Layer three: the device, and the narrow thing an approval means
The third layer is the one most often misquoted in marketing copy, and the misquote always runs in the same direction.
A device regulator evaluates devices. When the Food and Drug Administration approves a laser used in LASIK, it has reviewed evidence that a particular machine performs as intended within a defined range of correction, under specified conditions, for specified patients. The approval attaches to the equipment.
It does not attach to a surgeon, a clinic, or your result. No regulatory instrument anywhere certifies an individual patient's outcome, because outcome is not the kind of thing a pre-market review can promise. A laser approval says a tool was shown to do a job. It is silent on who wields it and on what happens in your particular cornea.
Two further limits are worth holding. An approval is bounded by the labeled range it was granted for, and treating a given eye is a physician's clinical judgment made inside or outside those bounds. And a US agency's approval is a US instrument: a laser installed in Seoul operates under Korean device regulation, so a platform's US approval is a fact about hardware history and nothing more.
The pattern across all three layers is now visible. The ministry answers "may this institution treat foreign patients." The society answers "did this physician complete specialty training." The device regulator answers "was this machine shown to work as described." Stack all three and the question you actually care about is still standing there unanswered.
So is LASIK safe? What the FDA publishes about risk
An honest answer comes from the risk literature, not the certificate wall. The Food and Drug Administration publishes the plainest version, and it is worth reading against the tone of most clinic material.
Some patients lose lines of best-corrected vision — meaning their vision with glasses afterward is worse than their vision with glasses before, and nothing restores it. Glare, halos and double vision can develop and can interfere with night driving. Contrast sensitivity, the ability to distinguish an object from a background of similar shade, can decline. Dry eye can occur and in some patients is severe and persistent. Not everyone achieves 20/20 without correction, and many patients still need reading glasses as they age, because the procedure does not address the age-related change in near focus.
The agency also notes that treating both eyes during a single session carries more risk than treating them in stages, and it cautions against selecting a provider on the strength of advertising, including guarantee-style promises about the result.
None of that is a reason not to have LASIK. Large numbers of people have the procedure and are satisfied. It is a reason to reject the framing that certification settles the clinical question. A fully registered institution, staffed by a fully certified surgeon, operating a fully approved laser, is performing a procedure with exactly this risk profile. The three layers govern who may operate and on what; they do not alter what the operation is.
This is why the pre-operative examination outweighs every certificate in the decision. The clinic's record places final eligibility on a comprehensive examination of roughly two hours, covering corneal shape, corneal thickness and health, pupil behavior under varying light, and the retina and optic nerve. Screening is where these risks are actually managed — by identifying the eyes that should not be treated.
The CDC's counterweight: what regulation cannot reach
The Centers for Disease Control and Prevention takes a deliberately unenthusiastic position on the value of paperwork. Its Yellow Book advises travelers to confirm accreditation before committing to care abroad — and states, in the same breath, that doing so does not by itself guarantee an outcome.
Two of its named risks apply directly here, and no credential discussed above touches either.
The first is communication difficulty. Consent, symptom description and post-operative instruction all run on language, and a misunderstanding at any of those points is a clinical event, not an administrative inconvenience. Jamsil Samsung Eye Clinic documents an in-house English support structure spanning inquiry through aftercare, but several specifics in its own records are marked as needing confirmation: the coordinator's identity and hours, what language the examination itself runs in, and who responds in English if a problem arises after you go home. The structure is documented; those details are open questions to put in writing.
The second is continuity of care, the structural weakness of the whole arrangement. The FDA expects post-operative review shortly after surgery and continued follow-up at intervals over a period of months. If the procedure happens in Seoul and the months happen at home, the regulatory chain has a geographic break in it: Korean registration, Korean certification and Korean oversight all stop at the airport. The CDC advises obtaining records in English before returning, which is the minimum bridge across that break. Arranging who will see you at home, in advance, is the rest of it.
Using the three layers without over-reading them
Together the framework gives you three checks of decreasing scope, and one large residual.
- Check the register yourself. The directory is public and searchable. It rules out the unregistered and ranks nobody.
- Confirm the insurance condition applies, in writing, rather than inferring it from the registration.
- Ask which body certified the surgeon assigned to you, then move past certification to experience with the specific procedure and platform.
- Treat device approvals as facts about equipment, not about the person operating it.
- Ask the questions certificates cannot answer, in writing: how eligibility is decided, what happens if screening rules you out after you arrive, what the retreatment position is, and who manages your follow-up once you are home.
Self-published material sits outside all of this. A clinic's own before-and-after gallery presents its own selected cases, which is normal and is not an outcome audit. Read it as illustration, and keep the register and the risk literature as your two anchors.
The Bottom Line
- Korea's Ministry of Health and Welfare registers institutions treating foreign patients under the Medical Overseas Expansion and Foreign Patients Attraction Act, and Medical Korea publishes a searchable directory you can check — a gatekeeping list, not a ranking.
- The substantive protection inside that scheme is the malpractice liability insurance condition Medical Korea describes as required of registered institutions since 2016: a remedy after harm, not a prevention of it. Registration is a different program from accreditation.
- Specialty certification through the Korean Ophthalmological Society confirms completed training in ophthalmology as a whole, not measured skill in refractive surgery, and a device approval covers a laser rather than a surgeon or a result.
- The FDA's published risks stand regardless: loss of best-corrected vision in some patients, glare and halos affecting night driving, dry eye that can persist, and no guarantee of 20/20 without correction.
- The CDC states that confirming accreditation is worthwhile but does not guarantee an outcome, and names communication difficulty and continuity-of-care gaps as risks no Korean credential reaches.
Frequently Asked Questions
Does Korean government registration mean LASIK at that clinic is safe?
No. Registration under the Medical Overseas Expansion and Foreign Patients Attraction Act confirms that the Ministry of Health and Welfare permits an institution to treat patients arriving from abroad, and that it has accepted the scheme's conditions. It involves no review of surgical results. The risks the Food and Drug Administration publishes for LASIK apply to registered and unregistered institutions alike.
Is registration the same as accreditation in Korea?
No. Medical Korea describes a registration system and a separate accreditation program as two distinct things. Registration is entry into a supervised category with stated conditions attached. Accreditation is an additional evaluation an institution may go through. A registered institution has not necessarily been accredited, so if accreditation matters to you, ask about it as its own question rather than reading it into a registration claim.
What does the Korean Ophthalmological Society actually certify?
It certifies training. As the national specialty society for ophthalmologists in Korea, it confirms that a physician completed a recognized residency in the specialty and met its standards. It publishes journals, hosts subspecialty societies including cornea and refractive surgery, and maintains a members' directory. It does not publish outcome data for individual surgeons or issue a separate certificate in refractive surgery.
Does FDA approval of a laser mean my surgery is FDA-approved?
No. The Food and Drug Administration evaluates devices. An approval means a specific machine was shown to perform as intended within a defined range of correction. It does not extend to the surgeon operating it, the clinic housing it, or the result in any individual eye. A US approval is also a US instrument, and equipment used in Korea is regulated under Korean device rules.
What are the main risks of LASIK that certification does not remove?
The Food and Drug Administration describes loss of lines of best-corrected vision in some patients that cannot be restored, glare, halos and double vision that can impair night driving, reduced contrast sensitivity, and dry eye that is sometimes severe and lasting. Not everyone reaches 20/20 without correction, and reading glasses may still be needed with age. The agency adds that operating on the second eye at a later sitting is the lower-risk course.
If something goes wrong after I return home, who is responsible?
That is the continuity-of-care gap the CDC's Yellow Book names, and it is the weakest joint in medical travel. Korean registration, the insurance condition attached to it, and Korean specialty certification all operate within Korea, while your follow-up happens where you live. The FDA expects review shortly after surgery and further checks over months. Obtain your records in English before leaving, and confirm before you travel which US practitioner will manage your follow-up.
This article is for general informational purposes and does not constitute individualized medical advice. No regulatory record can establish whether LASIK suits your eyes; only a qualified ophthalmologist, working from your own examination findings, is in a position to judge that. It is not a self-diagnosis tool.
More Articles
Continue reading our clinical ophthalmology guides.
LASIK Cost Korea vs US: How Each System Sets Prices
LASIK cost in Korea vs the US differs because each system treats vision correction as elective. How pricing is structured, and how to request a real quote.
Learn More
Dr. Kim Byoung Jin: Ophthalmologist in Seoul, Korea
Dr. Kim Byoung Jin is a board-certified ophthalmologist and representative director at Jamsil Samsung Eye Clinic, Seoul. His training and focus, explained.
Learn More
Book an Online Consultation: Korea Eye Clinic Guide
Book an online consultation with a Korea eye clinic: the channels this Seoul practice documents, the time-zone arithmetic, and what to assemble up front.
Learn More